Fatty liver disease, also called metabolic dysfunction-associated steatohepatitis (MASH), is a condition where fat ...

Researchers say semaglutide, the medication in Ozempic and Wegovy, may help reverse MASH, a progressive liver condition ...

The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new ...

The international study led by a Virginia Commonwealth University researcher found the medication semaglutide, commonly known ...

A late-stage clinical study showed that this weight loss drug helped 2 out of 3 people with the life-threatening liver ...

Nearly two in three people with fatty liver disease lost some of the liver fat and inflammation after using semaglutide 2.4 ...

A recent clinical trial reveals that Wegovy, a popular weight-loss drug containing semaglutide, shows promising results in ...

Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of ...

A large trial showed that the weight-loss drug could reduce liver inflammation and scarring caused by a common condition.

Prior to starting the trial, the participants also had moderate to high levels of scar tissue in the liver, known as stage 2 ...

This time next year, you may be swapping your GLP-1 injections for easier and as-effective oral weight-loss medication. It's ...

A new study published in the New England Journal of Medicine reveals that medications widely used for diabetes and obesity may offer significant benefits for patients with liver disease ...